BD Phoenix diagnostic panel recalled for drug cross-contamination
Becton Dickinson recalls BD Phoenix NMIC-306 microbiology diagnostic panels due to confirmed drug cross-contamination that may lead to incorrect bacterial identification and delayed treatment.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II diagnostic device with confirmed drug cross-contamination and potential for diagnostic errors impacting clinical treatment decisions. No hospitalizations, illnesses, or actual patient harm have been reported.
Plain-English summary
Becton Dickinson & Co. is recalling the BD Phoenix NMIC-306 Panel, a diagnostic microbiology panel used with BD Phoenix Automated Microbiology Systems to identify bacteria in clinical samples. The affected lot (number 3318700, expiration November 7, 2024) contains 11,800 units.
The panels were found to have confirmed drug cross-contamination prior to release. This contamination may lead to incorrect, inadequate, or absent antibiotic treatment recommendations if laboratories rely on the contaminated panels' test results for bacterial identification.
The affected products were distributed worldwide, including throughout the United States and to Argentina, Belgium, Colombia, India, Japan, Peru, Paraguay, Singapore, Taiwan, and Uruguay. Clinical laboratories and healthcare facilities using this product are potentially affected if they received the recalled lot.
The recalled product
- Product
- BD Phoenix NMIC-306 Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) polystyrene panel (tray) containing control wells and substrate wells with dried biochemical substrates that use traditional qualitative microbiology methods such as fermen
- Manufacturer
- Becton Dickinson & Co.
- Hazard
- contamination
- diagnostic-error
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Trays Recalled Due to Quality and Efficacy Concerns
FDA (Devices) · 2026-06-03
- HighMedline Medical Convenience Kit Recalled: Wrong Syringe Type Inside
FDA (Devices) · 2026-06-03
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03